Véronique Aubé

Acted on behalf of Celystra Pharma Inc., a Québec-based biopharmaceutical company, as part of an equity investment made by Investissement Québec and CIC Capital Canada Inc. Among other things, this transaction made it possible to finance the acquisition of Canadian marketing rights for two internationally developed innovative treatments for rare diseases.